Categories: News

Marengo Asia Hospitals acquires majority stake in 350-bed Sunshine Global Hospitals

NEW DELHI, Oct. 17, 2025 /PRNewswire/ — Marengo Asia Hospitals has further strengthened its Western India footprint with majority acquisition of Sunshine Global Hospitals — a prominent multi-specialty hospital chain in Gujarat with presence in Surat and Vadodara and a combined capacity of 350 beds. Both hospital units are NABH-accredited and offer more than 20 super-specialties.

- Advertisement -

Marengo Asia Hospitals focuses on providing tertiary and quaternary care, creating ‘Centers of Excellence’ across medical specialties, and adopting a ‘patient first’ approach. This acquisition further consolidates its presence in Gujarat where it already has two facilities located in Ahmedabad and Bhuj.

- Advertisement -

This acquisition follows Marengo Asia Hospitals’ recent expansions into Varanasi with Metis-The Medicity, marking its entry into a new state (Uttar Pradesh), and into the Kingdom of Saudi Arabia (KSA), marking its first international collaboration with Specialized Najran Hospital. With all these additions, Marengo Asia Hospitals now operates a total of 8 hospitals with a cumulative capacity of 2,500 beds, supported by a team of over 900 doctors and 5,200 employees.

- Advertisement -

“As we expand our presence in Western India, we are excited to enter 2 prominent cities of Vadodara and Surat and bring in our advanced tertiary and quaternary care expertise to the people of these cities and nearby areas,” said Dr. Raajiv Singhal, Founding Member, Managing Director and Group CEO, Marengo Asia Hospitals. “Every new hospital we bring into the Marengo Asia Hospitals’ network strengthens our commitment to the ‘Patient First’ approach — making specialized, affordable, and compassionate care accessible to more people, closer to their homes. Marengo Asia Hospitals aims to grow sustainably by developing clinical Centers of Excellence across specialties to deliver the best clinical outcomes for its patients.

- Advertisement -

About Marengo Asia Hospitals:

- Advertisement -

Marengo Asia Hospitals with its headquarter in NCR is a multi-specialty hospital chain focused on providing tertiary and quaternary care, creating ‘Centers of Excellence’ across medical specialties, and adopting a ‘Patient First’ approach. Its hospital network is currently spread across Northern and Western India. Marengo Asia Hospitals is founded and backed by Samara Capital, Havells and Godrej family offices and Dr Raajiv Singhal and is one of the fastest growing unlisted hospital chains with a revenue run-rate of ~ INR 1,200crs p.a.

- Advertisement -

Photo: https://mma.prnewswire.com/media/2798998/MAH_SGH_Deal_Signing.jpg

- Advertisement -

 

- Advertisement -

View original content to download multimedia:https://www.prnewswire.com/in/news-releases/marengo-asia-hospitals-acquires-majority-stake-in-350-bed-sunshine-global-hospitals-302587386.html

- Advertisement -

Recent Posts

From Checks to Systems: Regula Recognized Across Key Layers of Identity Verification in 2026 Cybersecurity Excellence Awards

RESTON, Va., April 07, 2026 (GLOBE NEWSWIRE) -- Identity verification (IDV) is shifting from a…

13 hours ago

Naitiv Launches as the First AI-Native ServiceNow Consultancy

Founded by longtime ServiceNow leaders from Thirdera, the firm launches with acquisitions and a strategic…

13 hours ago

IP Strategy Highlights Arias Frontline K-Pop Release with RESCENE on Story

GIG HARBOR, Wash., April 07, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST)…

13 hours ago

Emergent BioSolutions Launches New NARCAN Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced…

13 hours ago

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

April 07, 2026 08:05 ET  | Source: NextCure The U.S. Food and Drug Administration (FDA)…

13 hours ago

Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

April 07, 2026 08:00 ET  | Source: Valitor, Inc. BERKELEY, Calif., April 07, 2026 (GLOBE NEWSWIRE)…

13 hours ago